Council Members in this Study Group: 350
This study group may include experts knowledgeable on topics such as automotive manufacturing and dealerships, after market distribution, alcoholic and non-alcoholic beverages, convenience stores, supermarkets, packaged goods manufacturing, department stores and discounters, jewelry and cosmetics, hotels and resorts, restaurants, casinos, and the travel industry, among others.
Leading institutions connect with members of this Study Group through GLG
Keith AllenDirector, Cardiothoracic Vascular Surgery Research
Mid America Heart & Lung Surgeons, PC![]()
Keith Allen, MD, is a Director of Cardiothoracic-Vascular Surgery Research at the Mid America Heart Institute in Kansas City, Missouri. He is board certified in Thoracic, Vascular, and General Surgery. Dr. Allen maintains an active clinical research department...
Steven BelmontePresident & CEO
Hospitality Solutions LLC![]()
Steve Belmonte is the President, Chief Executive Officer, and Founder of Hospitality Solutions, a consulting company responsible for negotiations of hundreds of franchise agreements and termination claims. He has more than 35 years of experience in the...
J. Erik HvideChief Executive Officer
Magellan World Cruises, Inc.![]()
J. Erik Hvide is the Principal of HMS Consulting, where he has worked since 2000. HMS Consulting specializes in the offshore energy services and the cruise industry. Here, Mr. Hvide is responsible for strategic and M & A consulting for industry participants...
Senior Vice President & Executive in Charge
PKF CONSULTING, INC.![]()
John Fox is a Senior Vice President and Executive in Charge of PKF Consulting (New York), an international firm of management consultants, industry specialists, and appraisers who provide a full range of services to the hospitality, real estate, and tourism...
SVP, Bozeman Office
PKF CONSULTING, INC.![]()
Christopher Kraus is SVP in charge of the Bozeman, MT office at PKF Consulting, an international firm of management consultants, industry specialists, and appraisers who provide a full range of services to the hospitality, real estate, and tourism industries....
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Drug Eluting Stents:The Next Vioxx
December 14, 2006
Trading restenosis for Thrombosis? New questions about drug-eluding stents. | content.nejm.org
1. DES whether used on or off label will likely require life long anticoagulation with Plavix like drugs.
2. The incidence of late thrombosis is significant when anticoagulation is interrupted for events such as elective surgery.
3. Unlike restenosis following insertion of a bare metal stent which rarely results in death to the patient, late thrombosis following use of a DES results in a 50% mortality.
4. Hints of this problem were present during FDA presentations prior to DES approval which may lead to significant liability as this problem becomes more apparent.